相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma
Masato Saito et al.
BLOOD ADVANCES (2020)
Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-Lymphoma
Yui Suzuki et al.
CLINICAL CANCER RESEARCH (2019)
Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma
Atae Utsunomiya
FRONTIERS IN MICROBIOLOGY (2019)
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report
Lucy B. Cook et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment
Yuma Sakamoto et al.
BLOOD (2018)
Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals
Ayako Masaki et al.
CANCER SCIENCE (2018)
Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma
Masahito Tokunaga et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide survey
Kisato Nosaka et al.
CANCER SCIENCE (2017)
Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies
Takashi Ishida et al.
CANCER SCIENCE (2017)
Current status of immunotherapy
Susumu Suzuki et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality
Shigeo Fuji et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002
Takashi Ishida et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
Youko Suehiro et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study
Takashi Ishida et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab
Hideki Ifuku et al.
HEPATOLOGY RESEARCH (2015)
Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A)
Takuya Fukushima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Reactivation of hepatitis B virus in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab
Nobuaki Nakano et al.
HEPATOLOGY RESEARCH (2014)
Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma
Kenji Ishitsuka et al.
LANCET ONCOLOGY (2014)
StevensJohnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia/lymphoma
Takashi Ishida et al.
CANCER SCIENCE (2013)
Autologous Tax-Specific CTL Therapy in a Primary Adult T Cell Leukemia/Lymphoma Cell-Bearing NOD/Shi-scid, IL-2Rγnull Mouse Model
Ayako Masaki et al.
JOURNAL OF IMMUNOLOGY (2013)
Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study
Takashi Ishida et al.
BLOOD (2012)
Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma
Susumu Suzuki et al.
CANCER SCIENCE (2012)
Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/Lymphoma
Hiroo Katsuya et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
Takashi Ishida et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma
Toshihiko Ishii et al.
CLINICAL CANCER RESEARCH (2010)
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Makoto Miyara et al.
IMMUNITY (2009)
Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting
Kunihiro Tsukasaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
VCAP-AMP-VECP compared with biweekly CHOP for adult T-Cell leukemia-lymphoma: Japan clinical oncology group study JCOG9801
Kunihiro Tsukasaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Regulatory T-cell function of adult T-cell leukemia/lymphoma cells
Hiroki Yano et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Masao Matsuoka et al.
NATURE REVIEWS CANCER (2007)
CCR4 as a novel molecular target for immunotherapy of cancer
Takashi Ishida et al.
CANCER SCIENCE (2006)
CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified
T Ishida et al.
CLINICAL CANCER RESEARCH (2004)
The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma
T Ishida et al.
CLINICAL CANCER RESEARCH (2004)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells
O Yoshie et al.
BLOOD (2002)
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303
Y Yamada et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
分享论文
